(Q33385283)

English

Phase III study to evaluate temsirolimus compared with investigator's choice therapy for the treatment of relapsed or refractory mantle cell lymphoma

scientific article

In more languages
default for all languages
No label defined

No description defined

Statements

Phase III study to evaluate temsirolimus compared with investigator's choice therapy for the treatment of relapsed or refractory mantle cell lymphoma (English)
0 references
0 references
Christian Gisselbrecht

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit